In a mouse model of CML, BCR-ABL1-transduced progenitors from CD44-mutant donors were defective in BM homing, which resulted in decreased engraftment and impaired CML-like disease induction (100). This evidence concerns the gene CD44 and chronic myelogenous leukemia, BCR-ABL1 positive.